Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013 (2013), Article ID 379252, 10 pages
http://dx.doi.org/10.1155/2013/379252
Research Article

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study

1Health Economics and Epidemiology, Evidera, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
2Evidera, 430 Bedford Street, Suite 300, Lexington, MA 02420, USA
3Worldwide Epidemiology, GlaxoSmithKline, 1-3 Iron Bridge Road, Stockley Park West, Uxbridge, Middx UB11 1BT, UK
4Worldwide Epidemiology, GlaxoSmithKline, Five Moore Drive, P.O. Box 13398, Research Triangle Park, NC 27709, USA

Received 17 September 2013; Accepted 2 November 2013

Academic Editor: Vecihi Batuman

Copyright © 2013 Kathy H. Fraeman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Cutler, P. D. Sorlie, M. Wolz, T. Thom, L. E. Fields, and E. J. Roccella, “Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004,” Hypertension, vol. 52, no. 5, pp. 818–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. E. Fields, V. L. Burt, J. A. Cutler, J. Hughes, E. J. Roccella, and P. Sorlie, “The burden of adult hypertension in the United States 1999 to 2000: a rising tide,” Hypertension, vol. 44, no. 4, pp. 398–404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Yancik, M. N. Wesley, L. A. Ries et al., “Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study,” Cancer, vol. 82, no. 11, pp. 2123–2134, 1998. View at Google Scholar
  4. R. Yancik, M. N. Wesley, L. A. G. Ries, R. J. Havlik, B. K. Edwards, and J. W. Yates, “Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older,” The Journal of the American Medical Association, vol. 285, no. 7, pp. 885–892, 2001. View at Google Scholar · View at Scopus
  5. M. L. G. Janssen-Heijnen, R. M. Schipper, P. P. A. Razenberg, M. A. Crommelin, and J.-W. W. Coebergh, “Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study,” Lung Cancer, vol. 21, no. 2, pp. 105–113, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. G. Janssen-Heijnen, S. Smulders, V. E. P. P. Lemmens, F. W. J. M. Smeenk, H. J. A. A. van Geffen, and J. W. W. Coebergh, “Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer,” Thorax, vol. 59, no. 7, pp. 602–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. López-Encuentra, “Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients,” Lung Cancer, vol. 35, no. 3, pp. 263–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. W. Smith, B. B. Reeve, K. M. Bellizzi et al., “Cancer, comorbidities, and health-related quality of life of older adults,” Health Care Financing Review, vol. 29, no. 4, pp. 41–56, 2008. View at Google Scholar · View at Scopus
  9. C. Ko and S. Chaudhry, “The need for a multidisciplinary approach to cancer care,” Journal of Surgical Research, vol. 105, no. 1, pp. 53–57, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Havlik, R. Yancik, S. Long, L. Ries, and B. Edwards, “The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly,” Cancer, vol. 74, no. 7, supplement, pp. 2101–2106, 1994. View at Google Scholar · View at Scopus
  11. C. M. Tammemagi, D. Nerenz, C. Neslund-Dudas, C. Feldkamp, and D. Nathanson, “Comorbidity and survival disparities among black and white patients with breast cancer,” The Journal of the American Medical Association, vol. 294, no. 14, pp. 1765–1772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. F. Piccirillo, R. M. Tierney, I. Costas, L. Grove, and E. L. Spitznagel Jr., “Prognostic importance of comorbidity in a hospital-based cancer registry,” The Journal of the American Medical Association, vol. 291, no. 20, pp. 2441–2447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. W. A. Satariano and D. R. Ragland, “The effect of comorbidity on 3-year survival of women with primary breast cancer,” Annals of Internal Medicine, vol. 120, no. 2, pp. 104–110, 1994. View at Google Scholar · View at Scopus
  14. E. T. H. Yeh, “Cardiotoxicity induced by chemotherapy and antibody therapy,” Annual Review of Medicine, vol. 57, pp. 485–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. R. Townsend, “Hypertension and cancer chemotherapies,” in Advanced Therapy in Hypertension and Vascular Disease, E. R. Mohler and R. R. Townsend, Eds., pp. 502–507, BC Decker, Toronto, Canada, 2006. View at Google Scholar
  16. M. Jain and R. R. Townsend, “Chemotherapy agents and hypertension: a focus on angiogenesis blockade,” Current Hypertension Reports, vol. 9, no. 4, pp. 320–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. I. N. Daher and E. T. Yeh, “Vascular complications of selected cancer therapies,” Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 12, pp. 797–805, 2008. View at Google Scholar
  18. V. Ranpura, B. Pulipati, D. Chu, X. Zhu, and S. Wu, “Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis,” American Journal of Hypertension, vol. 23, no. 5, pp. 460–468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Cao, A. Tan, F. Gao, L. Liu, C. Liao, and Z. Mo, “A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer,” International Journal of Colorectal Disease, vol. 24, no. 6, pp. 677–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Izzedine, S. Ederhy, F. Goldwasser et al., “Management of hypertension in angiogenesis inhibitor-treated patients,” Annals of Oncology, vol. 20, no. 5, pp. 807–815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at Scopus